Navigation Links
Beryllium, Serum or Plasma

ProductsBeryllium, Serum or Plasma
Company ARUP Laboratories
Item Beryllium, Serum or Plasma
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Beryllium, Urine
2. SAFE-T-FILL Serum
3. SAFE-T-FILL Serum Mini Capillary Collection Tubes
4. SAFE-T-FILL Serum Gel Mini Capillary Collection Tubes
5. SAFE-T-FILL Serum Gel Capillary Collection Tubes
6. SAFE-T-FILL Serum Bili
7. SAFE-T-FILL Serum Bili Gel Capillary Collection Tubes
8. Lyphochek Maternal Serum Control
9. Liquichek Serum Volatiles Control
10. Lyphochek Drug-Free Serum
11. hCG Combo Urine/Serum - Rapid Test
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s
Provides gentle compression above and below implants
Bandeau Bra
Compression Bra
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ternational Human Genome Project (HGP) have identi...ighest concentration of disease genes.Out of 23 pa...ociated with genetic disease.Over the next 20 year...tre, near Cambridge, eastern England will have a l...
...iscovered fenfluramine, the diet medicine pulled f...d to heart valve problems, in Chinese herbal remed...ng to reports of this study, there has been seriou...mong a handful of patients led a group from Southe...
...sted that, along with calcium, protein may also an...nough calcium is essential for building and mainta...elderly men and women who were taking calcium citr...rs found that bone mineral density increased most ...
...identified a key mechanism disease-fighting cells ...n impose havoc with the digestive system and which...soning.An analysis of the defense tactics of the i...tigators to pinpoint a molecule that engineers sea...
Other Medicine News:Health News:Prohibited diet medicine found in Chinese herbs 2Health News:Calcium and Protein Equals Strong Bones 2Health News:Molecule aids fight E. Coli Infections 2Health News:Molecule aids fight E. Coli Infections 3
(Date:9/4/2008)...ented at ESC Congress-, PHILADELPHIA, Sept. 4 /PR...y, the GISSI Heart Failure (GISSI-HF) study, showe...uced all cause mortality and hospital,admissions f... heart,failure. These findings are published in th...presented at the European Cardiovascular Society (...
(Date:9/4/2008)...e/ -- Axentis Pharma AG has,initiated a clinical p...ty,of a new therapeutic formulation for the treatm...is patients. The new formulation allows an,establi... the site of,infection. The forthcoming trial will...f the new drug. Initial results are expected in su...
(Date:9/4/2008)...wo Abstracts Accepted for Presentation, and La...EWATER, N.J., Sept. 4 /- Aegerion Pha...pany focused on the treatment of,cardiovascular an...nt of,Peter L. Garrambone, Jr. to the Company,s bo...udes more than 50 pharmaceutical,transactions exec...
(Date:9/3/2008)... and Education Foundation,s Within Our Reach Camp... Treating and Understanding RA, A... during its,unprecedented initiative to find a cur...f Rheumatology Research and Education Foundation i... funded by the Within Our,Reach: Finding a Cure fo...
Breaking Medicine Technology:New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Southern Research Institute Names Vladimir Yamshchikov Director of Infectious Disease Research Department in Birmingham 5545 1Southern Research Institute Names Vladimir Yamshchikov Director of Infectious Disease Research Department in Birmingham 5545 2Breast Feeding Confers Long Term Heart Benefits 5541 1Breast Feeding Confers Long Term Heart Benefits 5541 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 754 1Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 754 2Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 754 3Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia 754 4AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 1AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 2AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 3AXA Equitable Makes it Easier to Stop Ignoring Life Insurance 5536 4
...-Apr 16, 2007 - Amgen,(Nasdaq:AMGN) today presente...cebo-controlled Phase 3 study evaluating the,effic...r the,treatment of anemia in patients with active ...("the 103 study"). Aranesp is not,approved for use...ts were presented in an oral session at the 2007 A...
... - Arsenic, a naturally,occurring element, has bee...rs, and even now remains a venerable constituent o...e in measure to the efforts of investigators suppo...rch Foundation,s,(SWCRF) "Institute Without Walls,...py for the treatment of certain types of acute,leu...
Other Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3